Future preventive and therapeutic obesity targets might include 5-HT, enkephalin L and neuromedin N, cinnamyl alcohol and 1 H-indole-3-acetamide. This evidence concerns the gene HTR5A and obesity due to melanocortin 4 receptor deficiency.